Most With Early AD Not Eligible for New Anti-Amyloid Drugs Most With Early AD Not Eligible for New Anti-Amyloid Drugs

Only a small percentage of people with early AD may be eligible to receive treatment, mostly due to chronic health conditions and brain scan abnormalities common in older adults.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery Source Type: news